A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age

NCT07082829 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

208

Enrollment

INDUSTRY

Sponsor class

Conditions

Excessive Daytime Sleepiness

Interventions

DRUG: ORX142 Tablets
OTHER: Placebo Tablets

Sponsor

Centessa Pharmaceuticals (UK) Limited